NANBIOSIS joined the launch of Misión Aragón: Cracks de la Ciencia, promoting scientific outreach and inspiring future generations through Aragón’s research excellence.
Zaragoza, July 2026 — NANBIOSIS took part in the presentation of Misión Aragón: Cracks de la Ciencia, a new science outreach initiative promoted by the Government of Aragón to inspire scientific vocations among young people by celebrating the region’s most influential researchers and world-class scientific infrastructures.
The initiative, presented on 30 July 2026 at the Pablo Serrano Museum in Zaragoza, introduces a collection of 15 collectible cards featuring ten outstanding Aragonese scientists and the five Unique Scientific and Technical Infrastructures (ICTS) located in Aragón, including NANBIOSIS. Through an engaging, game-based format, the project encourages children and families to discover the people, institutions and facilities that are shaping scientific progress while exploring the region of Aragón.

Representing CIBER-BBN and NANBIOSIS, Gabriel Alfranca, Internationalization and Communication Manager, attended the event and was interviewed about the importance of scientific infrastructures and communication in bringing research closer to society. His participation highlighted the role that research platforms such as NANBIOSIS play in supporting biomedical innovation and making cutting-edge science accessible beyond the laboratory.
Among the featured cards is CIBER-BBN, which can be collected at La Alfranca (Zaragoza) alongside the card dedicated to scientist Martina Bescós. By including leading research infrastructures in the collection, the initiative showcases the scientific ecosystem that enables discoveries with societal impact and encourages younger generations to engage with science and technology.
The event also acknowledged the recent National Research Award Juan de la Cierva for Knowledge Transfer received by Jesús Martínez de la Fuente, Research Professor at CSIC, researcher at INMA (CSIC–University of Zaragoza), and one of the Coordinators of CIBER-BBN. The award recognizes his outstanding career in nanobiotechnology and his exceptional contribution to transforming scientific research into real-world biomedical applications, reinforcing Aragón’s position as a hub for scientific excellence and innovation.

Through initiatives such as Misión Aragón: Cracks de la Ciencia, public institutions, research centres and scientific infrastructures are working together to promote scientific culture, foster STEAM vocations and inspire the next generation of researchers by demonstrating that science is both accessible and capable of transforming society.
What is NANBIOSIS?
The goal of NANBIOSIS is to provide comprehensive and integrated advanced solutions for companies and research institutions in biomedical applications. All of this is done through a single-entry point, involving the design and production of biomaterials, nanomaterials, and their nanoconjugates. This includes their characterization from physical-chemical, functional, toxicological, and biological perspectives (preclinical validation).
If you want to collaborate with us, visit our Order Request page.
Leading scientists
The main value of NANBIOSIS is our highly qualified and experienced academic scientists, working in public institutions, renowned universities and other research institutes.
Custom solutions
Designed for either scientific collaboration or the private industry, we adapt our services to your needs, filling the gaps and paving the way towards the next breakthrough.

Cutting-Edge facilities
Publicly funded, with the most advanced equipment, offering a wide variety of services from synthesis of nanoparticles and medical devices, including up to preclinical trials.
Standards of quality
Our services have standards of quality required in the pharmaceutical, biotech and medtech sectors, from Good Practices to ISO certifications.
In order to access our Cutting-Edge Biomedical Solutions with priority access, enter our Competitive Call here.
NANBIOSIS has worked with pharmaceutical companies of all sizes in the areas of drug delivery, biomaterials and regenerative medicine. Here are a few of them:








